These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30291583)

  • 21. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice.
    Petry H; Brooks A; Orme A; Wang P; Liu P; Xie J; Kretschmer P; Qian HS; Hermiston TW; Harkins RN
    Gene Ther; 2008 Jan; 15(1):54-60. PubMed ID: 17960164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient whole brain transduction by systemic infusion of minimally purified AAV-PHP.eB.
    Konno A; Hirai H
    J Neurosci Methods; 2020 Dec; 346():108914. PubMed ID: 32810474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient retinal ganglion cells transduction by retro-orbital venous sinus injection of AAV-PHP.eB in mature mice.
    Tang M; Zhong L; Rong H; Li K; Ye M; Peng J; Ge J
    Exp Eye Res; 2024 Jul; 244():109931. PubMed ID: 38763353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9.
    Chatterjee D; Marmion DJ; McBride JL; Manfredsson FP; Butler D; Messer A; Kordower JH
    Gene Ther; 2022 Jun; 29(6):390-397. PubMed ID: 33753910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AAV-PHP.B-Mediated Global-Scale Expression in the Mouse Nervous System Enables GBA1 Gene Therapy for Wide Protection from Synucleinopathy.
    Morabito G; Giannelli SG; Ordazzo G; Bido S; Castoldi V; Indrigo M; Cabassi T; Cattaneo S; Luoni M; Cancellieri C; Sessa A; Bacigaluppi M; Taverna S; Leocani L; Lanciego JL; Broccoli V
    Mol Ther; 2017 Dec; 25(12):2727-2742. PubMed ID: 28882452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An adeno-associated virus-based intracellular sensor of pathological nuclear factor-κB activation for disease-inducible gene transfer.
    Chtarto A; Bockstael O; Gebara E; Vermoesen K; Melas C; Pythoud C; Levivier M; De Witte O; Luthi-Carter R; Clinkers R; Tenenbaum L
    PLoS One; 2013; 8(1):e53156. PubMed ID: 23301037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates.
    Gray SJ; Nagabhushan Kalburgi S; McCown TJ; Jude Samulski R
    Gene Ther; 2013 Apr; 20(4):450-9. PubMed ID: 23303281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction.
    Fitzpatrick Z; Leborgne C; Barbon E; Masat E; Ronzitti G; van Wittenberghe L; Vignaud A; Collaud F; Charles S; Simon Sola M; Jouen F; Boyer O; Mingozzi F
    Mol Ther Methods Clin Dev; 2018 Jun; 9():119-129. PubMed ID: 29766022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glial promoter selectivity following AAV-delivery to the immature brain.
    von Jonquieres G; Mersmann N; Klugmann CB; Harasta AE; Lutz B; Teahan O; Housley GD; Fröhlich D; Krämer-Albers EM; Klugmann M
    PLoS One; 2013; 8(6):e65646. PubMed ID: 23799030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice.
    Torregrosa T; Lehman S; Hana S; Marsh G; Xu S; Koszka K; Mastrangelo N; McCampbell A; Henderson CE; Lo SC
    Gene Ther; 2021 Aug; 28(7-8):456-468. PubMed ID: 33612827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain.
    Peden CS; Burger C; Muzyczka N; Mandel RJ
    J Virol; 2004 Jun; 78(12):6344-59. PubMed ID: 15163728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.B.
    Dayton RD; Grames MS; Klein RL
    Gene Ther; 2018 Aug; 25(5):392-400. PubMed ID: 30013186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transduction Profile of the Marmoset Central Nervous System Using Adeno-Associated Virus Serotype 9 Vectors.
    Matsuzaki Y; Konno A; Mukai R; Honda F; Hirato M; Yoshimoto Y; Hirai H
    Mol Neurobiol; 2017 Apr; 54(3):1745-1758. PubMed ID: 26884266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
    Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
    Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies.
    Sun J; Hua B; Chen X; Samulski RJ; Li C
    Hum Gene Ther; 2017 Aug; 28(8):654-666. PubMed ID: 28478688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of high-content imaging to quantify transduction of AAV-PHP viruses in the brain following systemic delivery.
    Smith EJ; Farshim PP; Flomen R; Jones ST; McAteer SJ; Deverman BE; Gradinaru V; Bates GP
    Brain Commun; 2021; 3(2):fcab105. PubMed ID: 34131644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5
    Majowicz A; Salas D; Zabaleta N; Rodríguez-Garcia E; González-Aseguinolaza G; Petry H; Ferreira V
    Mol Ther; 2017 Aug; 25(8):1831-1842. PubMed ID: 28596114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preexisting Neutralizing Antibodies to Adeno-Associated Virus Capsids in Large Animals Other Than Monkeys May Confound In Vivo Gene Therapy Studies.
    Calcedo R; Franco J; Qin Q; Richardson DW; Mason JB; Boyd S; Wilson JM
    Hum Gene Ther Methods; 2015 Jun; 26(3):103-5. PubMed ID: 26067568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful liver transduction by re-administration of different adeno-associated virus vector serotypes in mice.
    Baatartsogt N; Kashiwakura Y; Hiramoto T; Hayakawa M; Kamoshita N; Ohmori T
    J Gene Med; 2023 Aug; 25(8):e3505. PubMed ID: 36972408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.